Recursion Pharmaceuticals Inc
RXRX
Company Profile
Business description
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Contact
41 S Rio Grande Street
Salt Lake CityUT84101
USAT: +1 385 269-0203
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
800
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,564.70 | 47.00 | -0.55% |
| CAC 40 | 7,910.49 | 31.93 | -0.40% |
| DAX 40 | 24,122.40 | 86.29 | 0.36% |
| Dow JONES (US) | 41,860.44 | 816.80 | -1.91% |
| FTSE 100 | 8,786.46 | 5.34 | 0.06% |
| HKSE | 23,695.88 | 131.90 | -0.55% |
| NASDAQ | 18,872.64 | 270.07 | -1.41% |
| Nikkei 225 | 36,930.94 | 368.04 | -0.99% |
| NZX 50 Index | 12,644.64 | 58.46 | -0.46% |
| S&P 500 | 5,844.61 | 95.85 | -1.61% |
| S&P/ASX 200 | 8,343.20 | 43.60 | -0.52% |
| SSE Composite Index | 3,387.63 | 0.05 | 0.00% |